Elevance Health announced on April 17, 2025, that it expects first-quarter profit to be above analyst estimates, with medical cost trends aligning with its expectations. The company anticipates reporting first-quarter earnings of $9.61 per share, or $11.97 per share on an adjusted basis, surpassing the FactSet analyst projection of $11.32 per share.
This positive preliminary outlook contrasts with a disappointing report from UnitedHealth Group on the same day, highlighting Elevance Health's ability to manage costs effectively. The company reaffirmed its full-year adjusted earnings guidance of $34.15 to $34.85 per share for 2025.
Elevance Health stated that while Medicare Advantage costs were elevated during the quarter, they were consistent with its expectations and pricing strategies. The company continues to project Medicare Advantage membership of 2.2 million to 2.25 million members by year-end 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.